Here are six trends:
1. The market was valued at $22.6 billion in 2015.
2. The market is expected to reach $36.5 billion by 2022.
3. It is predicted to grow at a compound annual growth rate of 7 percent through 2022.
4. The growing incidence of gastrointestinal conditions and colon cancer as well as the high demand for minimally invasive surgeries will spur the market’s growth.
5. The availability of favorable reimbursement policies for endoscopic procedures will also contribute to the market’s growth.
6. The Asia-Pacific region is the fastest growing regional market, due to growing medical tourism and development of enhanced healthcare infrastructure.
More articles on GI/endoscopy:
EndoGastric Solutions receives medical coverage for TIF procedure with EsophyX device, Takeda & Altos partner to develop gastroparesis treatment & more — 4 GI company key notes
AGA, Pfizer offer new IBD-related research grants: 4 notes
UCLA researchers identify risk factors for tainted scopes’ bacteria transmission — 5 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.